Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a major cause of infertility in women of childbearing age.

Continuous research and innovative strategies are essential for sustainable development.

The conference emphasized innovative solutions for global challenges, including disaster architecture, education, health, and economic impacts.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

Melatonin implants and long daylight hours alter the timing of hormone release and hair growth in mouflon sheep.

Women with a certain type of hair loss had lower levels of a hormone called prolactin compared to healthy women.

High prolactin and low vitamin D levels may be linked to hair loss in women.

Too much prolactin can cause menstrual problems, infertility, and sexual issues in women.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Hormonal imbalances contribute to female hair loss, and trichoscopy is a useful diagnostic tool.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

TRH stimulates human hair growth and extends the hair growth phase.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Melatonin may help with sleep issues, depression, and cancer, but more research is needed.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Ovulation disorders are a major cause of infertility and menstrual problems in women.